Skip to content
10-K

Annual Report

NUTRA PHARMA CORP. NPHC

0001493152-25-024800

← back to feed
Filed
Nov 24, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Nov 24, 2025 7.1B sh
Short Term Debt FY 2023 · Dec 31, 2023 $8.33M
Short Term Debt FY 2023 · Dec 31, 2022 $7.93M
Shares Diluted FY 2023 · Dec 31, 2022 19.1B sh
Capex FY 2023 · Dec 31, 2022 $57.99K
Operating Cash Flow FY 2023 · Dec 31, 2022 −$762.43K
Cash And Equivalents FY 2023 · Dec 31, 2022 $0
Current Liabilities FY 2023 · Dec 31, 2022 $12.7M
Total Liabilities FY 2023 · Dec 31, 2022 $13.13M
Current Assets FY 2023 · Dec 31, 2022 $333.58K
Total Assets FY 2023 · Dec 31, 2022 $754.91K
Eps Diluted restated FY 2023 · Dec 31, 2022 $0.00
Eps Basic restated FY 2023 · Dec 31, 2022 $0.00
Sga Expense FY 2023 · Dec 31, 2022 $2.08M
Net Income FY 2023 · Dec 31, 2022 $8.18M
Operating Income FY 2023 · Dec 31, 2022 −$1.91M
Gross Profit FY 2023 · Dec 31, 2022 $249.02K
Revenue restated FY 2023 · Dec 31, 2022 $145.8K
Stockholders Equity FY 2023 · Dec 31, 2021 −$20.88M